Afon Technology Ltd, registered in England and Wales under registration number 09700231, is an active limited company established in 2015. The company operates from Unit 670 Castlegate Business Park, Caldicot, NP26 5AD. It is classified under SIC 72110 – Research and experimental development on biotechnology. The company’s primary focus is the development of a non-invasive, continuous blood glucose monitor for individuals with diabetes. Website findings indicate the company size is not specified, but its operations center around research and experimental development within the biotechnology sector. Afon Technology Ltd is a limited company (Ltd). Financial records for the year ending 2024-12-31 show no charges and the company is not insolvent. Visa information indicates the company holds a Skilled Worker visa, with a rating of Worker (A rating). The company’s mission is centered on diabetes monitoring and the development of a novel continuous glucose monitoring solution. There is no evidence of international presence or current hiring activity. The company’s operational scale is not readily available from the provided data, but it is engaged in research and development activities related to biotechnology.

Afon Technology Ltd, registered in England and Wales under registration number 09700231, is an active limited company established in 2015. The company operates from Unit 670 Castlegate Business Park, Caldicot, NP26 5AD. It is classified under SIC 72110 – Research and experimental development on biotechnology. The company’s primary focus is the development of a non-invasive, continuous blood glucose monitor for individuals with diabetes. Website findings indicate the company size is not specified, but its operations center around research and experimental development within the biotechnology sector. Afon Technology Ltd is a limited company (Ltd). Financial records for the year ending 2024-12-31 show no charges and the company is not insolvent. Visa information indicates the company holds a Skilled Worker visa, with a rating of Worker (A rating). The company’s mission is centered on diabetes monitoring and the development of a novel continuous glucose monitoring solution. There is no evidence of international presence or current hiring activity. The company’s operational scale is not readily available from the provided data, but it is engaged in research and development activities related to biotechnology.